THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 83 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209,870 | -8.4% | 18,705 | -9.8% | 0.01% | -57.1% |
| Q4 2021 | $229,000 | +17.4% | 20,729 | +57.4% | 0.01% | +7.7% |
| Q3 2020 | $195,000 | -16.7% | 13,167 | +18.3% | 0.01% | -18.8% |
| Q2 2020 | $234,000 | +7.8% | 11,126 | +85.6% | 0.02% | -66.7% |
| Q3 2016 | $217,000 | -20.8% | 5,995 | -50.3% | 0.05% | +33.3% |
| Q2 2016 | $274,000 | -54.6% | 12,056 | -78.1% | 0.04% | -30.8% |
| Q3 2015 | $604,000 | – | 55,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |